Outset Medical, Inc. Operating Income
Outset Medical, Inc. (OM) reported Operating Income of -$15.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Outset Medical, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$15.68M.
- Outset Medical, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$16.92M.
- Outset Medical, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$17.63M.
- Outset Medical, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$15.81M.
- Outset Medical, Inc. operating income (loss) for fiscal 2025 was -$66.71M.
- Outset Medical, Inc. operating income (loss) for fiscal 2024 was -$113.38M.
- Outset Medical, Inc. operating income (loss) for fiscal 2023 was -$169.77M.
- Outset Medical, Inc. operating income (loss) for fiscal 2022 was -$161.02M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.68M 10-Q · filed 2026-08-06 | -$32.59M 10-Q · filed 2026-08-06 | -$50.22M derived: sum of 3 quarters · filed 2026-08-06 | -$66.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$16.92M 10-Q · filed 2026-05-07 | -$34.55M derived: sum of 2 quarters · filed 2026-05-07 | -$50.36M derived: sum of 3 quarters · filed 2026-05-07 | -$67.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$17.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$33.44M derived: sum of 2 quarters · filed 2026-02-13 | -$50.31M derived: sum of 3 quarters · filed 2026-08-06 | -$66.71M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$15.81M 10-Q · filed 2025-11-10 | -$32.68M derived: sum of 2 quarters · filed 2026-08-06 | -$49.08M 10-Q · filed 2025-11-10 | -$70.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$16.86M 10-Q · filed 2026-08-06 | -$33.26M 10-Q · filed 2026-08-06 | -$55.12M derived: sum of 3 quarters · filed 2026-08-06 | -$78.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$16.40M 10-Q · filed 2026-05-07 | -$38.26M derived: sum of 2 quarters · filed 2026-05-07 | -$62.10M derived: sum of 3 quarters · filed 2026-05-07 | -$92.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$21.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$45.70M derived: sum of 2 quarters · filed 2026-02-13 | -$76.46M derived: sum of 3 quarters · filed 2026-02-13 | -$113.38M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$23.84M 10-Q · filed 2025-11-10 | -$54.60M derived: sum of 2 quarters · filed 2025-11-10 | -$91.52M 10-Q · filed 2025-11-10 | -$128.87M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$30.76M 10-Q · filed 2025-08-07 | -$67.68M 10-Q · filed 2025-08-07 | -$105.03M derived: sum of 3 quarters · filed 2026-02-13 | -$150.48M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$36.91M 10-Q · filed 2025-05-08 | -$74.27M derived: sum of 2 quarters · filed 2026-02-13 | -$119.72M derived: sum of 3 quarters · filed 2026-02-13 | -$163.20M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$37.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$82.81M derived: sum of 2 quarters · filed 2026-02-13 | -$126.28M derived: sum of 3 quarters · filed 2026-02-13 | -$169.77M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$45.45M 10-Q · filed 2024-11-07 | -$88.93M derived: sum of 2 quarters · filed 2024-11-07 | -$132.42M 10-Q · filed 2024-11-07 | -$172.24M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$43.48M 10-Q · filed 2024-08-08 | -$86.96M 10-Q · filed 2024-08-08 | -$126.79M derived: sum of 3 quarters · filed 2025-02-28 | -$167.79M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$43.48M 10-Q · filed 2024-05-09 | -$83.31M derived: sum of 2 quarters · filed 2025-02-28 | -$124.31M derived: sum of 3 quarters · filed 2025-02-28 | -$168.03M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$39.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$80.82M derived: sum of 2 quarters · filed 2025-02-28 | -$124.54M derived: sum of 3 quarters · filed 2025-02-28 | -$161.02M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$41.00M 10-Q · filed 2023-11-08 | -$84.72M derived: sum of 2 quarters · filed 2023-11-08 | -$121.19M 10-Q · filed 2023-11-08 | -$161.99M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$43.72M 10-Q · filed 2023-08-03 | -$80.20M 10-Q · filed 2023-08-03 | -$121.00M derived: sum of 3 quarters · filed 2024-02-21 | -$151.13M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$36.48M 10-Q · filed 2023-05-04 | -$77.27M derived: sum of 2 quarters · filed 2024-02-21 | -$107.41M derived: sum of 3 quarters · filed 2024-02-21 | -$137.32M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$40.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$70.94M derived: sum of 2 quarters · filed 2024-02-21 | -$100.84M derived: sum of 3 quarters · filed 2024-02-21 | -$130.52M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$30.14M 10-Q · filed 2022-11-09 | -$60.04M derived: sum of 2 quarters · filed 2022-11-09 | -$89.72M 10-Q · filed 2022-11-09 | -$121.33M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | -$29.91M 10-Q · filed 2022-08-02 | -$59.58M 10-Q · filed 2022-08-02 | -$91.20M derived: sum of 3 quarters · filed 2023-02-13 | -$131.93M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | -$29.68M 10-Q · filed 2022-05-05 | -$61.29M derived: sum of 2 quarters · filed 2023-02-13 | -$102.02M derived: sum of 3 quarters · filed 2023-02-13 | -$126.93M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$31.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$72.35M derived: sum of 2 quarters · filed 2023-02-13 | -$97.26M derived: sum of 3 quarters · filed 2023-02-13 | -$117.47M 10-K · filed 2023-02-13 |
| 2020-09-30 | -$40.73M 10-Q · filed 2021-11-04 | -$65.64M derived: sum of 2 quarters · filed 2021-11-04 | -$85.85M 10-Q · filed 2021-11-04 | -$104.42M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$24.91M 10-Q · filed 2021-08-06 | -$45.12M 10-Q · filed 2021-08-06 | -$63.69M derived: sum of 3 quarters · filed 2022-02-23 | -$82.14M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$20.21M 10-Q · filed 2021-05-06 | -$38.78M derived: sum of 2 quarters · filed 2022-02-23 | -$57.23M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | -$18.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$37.02M derived: sum of 2 quarters · filed 2022-02-23 | -$70.31M 10-K · filed 2022-02-23 | |
| 2019-09-30 | -$18.45M 10-Q · filed 2020-11-12 | -$51.74M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | -$46.56M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |